Ana içeriğe geç
Ear, Nose & Throat

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 July 2026

PRAC agrees new safety information on desogestrel- and etonogestrel-containing contraceptives and Litfulo, a medicine to treat alopecia areata   Desogestrel- and etonogestrel-…, Agenda Agenda of the PRAC meeting 6-9 July 2026Draft Refer

EC
EuroClinics Editorial 10 July 2026
1 min read
PRAC agrees new safety information on desogestrel- and etonogestrel-containing contraceptives and Litfulo, a medicine to treat alopecia areata   Desogestrel- and etonogestrel-…, Agenda Agenda of the PRAC meeting 6-9 July 2026Draft Reference Number: EMA/PRAC/141965/2026…, PRAC statistics: July 2026 , PRAC statistics: July 2026 English (EN) (174.12 KB - PDF)First published: 10/07/2026 View , Glossary Safety signal assessments. A safety signal is information which suggests a new potentially causal association, or a new aspect of a known association between…
EC

EuroClinics Editorial

Patient-facing healthcare guidance

Our editorial team distils the latest from European medical authorities (WHO Europe, ECDC, EMA, NHS, AEMPS, HAS) into plain-language guides for patients. Every article is reviewed against authoritative sources.

🏥

Need ear, nose & throat in Europe?

Browse verified clinics with transparent pricing and real reviews across 30+ countries.

Find a clinic →
Source. European Medicines Agency — European Medicines Agency, CC BY 4.0
Medical disclaimer. Articles are general information aggregated from third-party medical sources. They are NOT a substitute for in-person diagnosis or treatment. For personal medical guidance, consult a verified clinician or call your local emergency line (112 in the EU).